Graybug Vision Completes Treatment Phase of ALTISSIMO Trial in Wet AMD with 12-Month Topline Data Expected in Second Quarter 2021
January 07, 2021 07:30 ET
|
Graybug Vision, Inc.
REDWOOD CITY, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines to treat...
ONL Therapeutics Closes $46.9 Million in Series B Financing to Advance ONL1204 into Three Retinal Disease Indications
December 22, 2020 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., Dec. 22, 2020 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, today...
Outlook on the Choroidal Neovascularization Global Market to 2025 - Impact Analysis of COVID-19
December 03, 2020 06:23 ET
|
Research and Markets
Dublin, Dec. 03, 2020 (GLOBE NEWSWIRE) -- The "Choroidal Neovascularization Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...
Cross Keys Capital Advises Retina Associates of Sarasota on Their Partnership with Retina Consultants of America
November 18, 2020 15:44 ET
|
Cross Keys Capital, LLC.
Fort Lauderdale, Florida, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Cross Keys Capital served as the exclusive M&A advisor to Retina Associates of Sarasota (RAS) in its partnership with Retina...
Graybug Vision to Participate in the 32nd Annual Piper Sandler Healthcare Conference
November 16, 2020 16:05 ET
|
Graybug Vision, Inc.
REDWOOD CITY, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the...
Graybug Vision Announces Financial Results for the Three and Nine Months Ended September 30, 2020 and Recent Corporate Developments
November 12, 2020 16:05 ET
|
Graybug Vision, Inc.
REDWOOD CITY, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the...
Worldwide Retinal Implants Industry to 2025 - North America is Expected to Dominate the Market
November 02, 2020 04:28 ET
|
Research and Markets
Dublin, Nov. 02, 2020 (GLOBE NEWSWIRE) -- The "Retinal Implants Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The retinal...
Global Prescription Lens Market Outlook to 2027 - Featuring Prive Revaux, ZEISS International & Rodenstock Among Others
October 13, 2020 06:14 ET
|
Research and Markets
Dublin, Oct. 13, 2020 (GLOBE NEWSWIRE) -- The "Prescription Lens - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. According to the report, the...
Insights on the Pupillometer Global Market to 2026 - Industry Analysis and Forecast
October 07, 2020 06:59 ET
|
Research and Markets
Dublin, Oct. 07, 2020 (GLOBE NEWSWIRE) -- The "Global Pupillometer Market by Mobility, by End Use, by Type, by Application, by Region, Industry Analysis and Forecast, 2020 - 2026" report has been...
Graybug Appoints Three New Members to its Board of Directors
September 25, 2020 08:00 ET
|
Graybug Vision, Inc.
REDWOOD CITY, Calif., Sept. 25, 2020 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines to treat...